pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Arbitrators profit heavily from No Surprises Act disputes, raising concerns over health-care billing practices

Oct 19, 2026·read at STAT ↗Negative

The STAT Health Care Inc. newsletter reports that the arbitration mechanism created by the No Surprises Act, intended to resolve out-of-network billing conflicts, has become a lucrative business for the arbitrators who decide the outcomes.

According to the article, some arbitrators are earning profit margins comparable to large technology firms, as noted by reporter Tara Bannow.

The piece also references broader themes such as trust, pricing, and a side note about Major League Baseball job lock, but the focus remains on the financial incentives built into the arbitration process.

The newsletter highlights the need for scrutiny of how the arbitration system operates, given its impact on both patients and providers.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: The umpires getting rich off surprise medical bills, and MLB job lock”

read at STAT ↗
499 words · retrieved 45m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Protara Therapeutics, Inc.2
topics
Oncology2AdComApprovalKRAS

related stories

  • 8h agoSTAT+: How the No Surprises Act’s nonprofit arbitrators are operating like ‘mini gods’ and getting rich doing itSTAT
  • 3d agoMerck and Moderna have ‘lot of exploring to do’ after initial cancer vaccine successSTAT
  • 4d agoSTAT+: Verastem’s KRAS inhibitor shows promise in pancreatic cancerSTAT
  • Jun 26FDA accepts Replimune filing; Merck KGaA drops $11B on life sciences servicesBioPharma Dive
  • May 6ASCO 2026 HR+ and HER2+ Breast Cancer Preview: Read up on the Insights to Know Before You Goonclive